Jim Simons Bio Affinity Technologies, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 22,967 shares of BIAF stock, worth $47,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,967
Previous 37,500
38.75%
Holding current value
$47,312
Previous $76,000
35.53%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
400KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA172KShares$354,3070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA69.6KShares$143,3760.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$57,4430.0% of portfolio
-
Ground Swell Capital, LLC Folly Beach, SC22.9KShares$47,0990.04% of portfolio
-
State Street Corp Boston, MA17.6KShares$36,2560.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $5.62M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...